0001567619-22-007042.txt : 20220316
0001567619-22-007042.hdr.sgml : 20220316
20220316154754
ACCESSION NUMBER: 0001567619-22-007042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiraly Thomas E
CENTRAL INDEX KEY: 0001623986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 22744759
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2022-03-15
0
0000722723
HANGER, INC.
HNGR
0001623986
Kiraly Thomas E
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2022-03-15
4
S
0
8750
19.1555
D
254854
D
Stock Options (right to buy)
12.77
2027-05-19
Common Stock
31389
31389
D
The sale by Mr. Kiraly was effected automatically upon the satisfaction of certain timing, trading price and other conditions under a trading plan designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. Mr. Kiraly entered into this trading plan on November 15, 2021, and up to 26,250 additional shares could be sold through periodic quarterly sales that may occur under this plan through the end of 2022 if the conditions of the plan are met.
These shares were sold at a range of sale prices from $18.86 to $19.47. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Stock options were granted under the Company's Special Equity Plan and vested 1/3 on each of May 19, 2018, 2019 and 2020.
Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Kiraly
2022-03-16